Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Hosp Palliat Care. 2006 Jan-Feb;23(1):35-40.

Use of methylphenidate in patients with cancer.

Author information

  • 1Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.

Abstract

Cancer and its treatment are often associated with symptoms such as depression, somnolence, cognitive abnormalities, and fatigue. Methylphenidate, a stimulant medication, is commonly used to treat these symptoms. Several small pilot and a few adequately powered studies have assessed the safety and efficacy of methylphenidate in patients with cancer Overall, the studies so far suggest that methylphenidate is well-tolerated in patients with cancer Further, the studies have provided initial evidence of efficacy of this agent in patients with cancer The present article reviews the evidence base behind the use of methylphenidate in these patients.

PMID:
16450661
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk